A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer (KEYNOTE- 826)

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

Effective start/end date27/04/2126/04/26


  • clinical trial
  • phase 1 and 2 study
  • treatment safety
  • treatment efficacy
  • Metastatic Cancer